Evidence map›Paper›PMID 33727636›Full record

ArticleNPJ digital medicine2021

Reopening businesses and risk of COVID-19 transmission.

Ashley O'Donoghue, Tenzin Dechen, Whitney Pavlova, Michael Boals, Garba Moussa, Manvi Madan, Aalok Thakkar, Frank J DeFalco, Jennifer P Stevens

Erratum issuedAbstract read
In one paragraph

Article in NPJ digital medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. COVID-19 economic policy effects on consumer spending and foot traffic in the U.S.Journal of safety science and resilience = An quan ke xue yu ren xing (Ying wen) · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ashley O'DonoghueCenter for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA. aodonogh@bidmc.harvard.edu.ORCID http://orcid.org/0000-0001-7401-5692
Tenzin DechenCenter for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Whitney PavlovaDepartment of Statistics, Pennsylvania State University, University Park, PA, USA.
Michael BoalsRequisite Analytics, Berkeley, CA, USA.
Garba MoussaOpen-Classroom, Paris, France.
Manvi MadanPorts of Auckland, Auckland, New Zealand.
Aalok ThakkarUniversity of Pennsylvania, Philadelphia, PA, USA.
Frank J DeFalcoJanssen Research & Development, Titusville, NJ, USA.
Jennifer P StevensCenter for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Funding

A multistakeholder examination of the drivers and value of inpatient consultationK08HS024288 · AHRQ · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STEVENS, JENNIFER P · 2016 to 2020
$752k
AHRQ HHS K08 HS024288
6 · The paper itself

Abstract

The true risk of a COVID-19 resurgence as states reopen businesses is unknown. In this paper, we used anonymized cell-phone data to quantify the potential risk of COVID-19 transmission in business establishments by building a Business Risk Index that measures transmission risk over time. The index was built using two metrics, visits per square foot and the average duration of visits, to account for both density of visits and length of time visitors linger in the business. We analyzed trends in traffic patterns to 1,272,260 businesses across eight states from January 2020 to June 2020. We found that potentially risky traffic behaviors at businesses decreased by 30% by April. Since the end of April, the risk index has been increasing as states reopen. There are some notable differences in trends across states and industries. Finally, we showed that the time series of the average Business Risk Index is useful for forecasting future COVID-19 cases at the county-level (P < 0.001). We found that an increase in a county's average Business Risk Index is associated with an increase in positive COVID-19 cases in 1 week (IRR: 1.16, 95% CI: (1.1-1.26)). Our risk index provides a way for policymakers and hospital decision-makers to monitor the potential risk of COVID-19 transmission from businesses based on the frequency and density of visits to businesses. This can serve as an important metric as states monitor and evaluate their reopening strategies.

Identifiers

PMID33727636
PMCPMC7966767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.